PULM Projected Dividend Yield
Com Par $0.0001/Pulmatrix Inc ( NASDAQ : PULM )Pulmatrix, Inc. is a clinical-stage biopharmaceutical company. Co. is focused on the development of novel inhaled therapeutic products intended to prevent and treat respiratory and other diseases with important unmet medical needs using its patented iSPERSE technology. Co.'s proprietary product pipeline includes treatments for central nervous system (CNS) disorders, such as acute migraine and serious lung diseases, such as chronic obstructive pulmonary disease (COPD) and allergic bronchopulmonary aspergillosis (ABPA). 21 YEAR PERFORMANCE RESULTS |
PULM Dividend History Detail PULM Dividend News PULM Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |